Treatment of vulvar cancer recurrences with electrochemotherapy – a detailed analysis of possible causes for unsuccessful treatment

1United States Cancer Statistics (USCS). U.S. Cancer Statistics Data Visualizations Tool. CDC, Centers for Disease Control and prevention. May 24, 2022. [cited 2022 Aug 19]. Available at: https://www.cdc.gov/cancer/uscs/dataviz/index.htm United States Cancer Statistics (USCS) U.S. Cancer Statistics Data Visualizations Tool. CDC, Centers for Disease Control and prevention May 24 2022 [cited 2022 Aug 19]. Available at https://www.cdc.gov/cancer/uscs/dataviz/index.htmSearch in Google Scholar

2Merlo S. Modern treatment of vulvar cancer. Radiol Oncol 2020; 54: 371-6. doi: 10.2478/raon-2020-0053 Merlo S Modern treatment of vulvar cancer Radiol Oncol 2020 54 371 6 doi 10.2478/raon-2020-0053Open DOISearch in Google Scholar

3Salom EM, Penalver M. Recurrent vulvar cancer. Curr Treat Options Oncol 2002; 3: 143-53. doi: 10.1007/s11864-002-0060-x Salom EM Penalver M Recurrent vulvar cancer Curr Treat Options Oncol 2002 3 143 53 doi 10.1007/s11864-002-0060-xOpen DOISearch in Google Scholar

4Cemazar M, Sersa G. Recent advances in electrochemotherapy. Bioelectricity 2019; 1: 204-13. doi: 10.1089/bioe.2019.0028 Cemazar M Sersa G Recent advances in electrochemotherapy Bioelectricity 2019 1 204 13 doi 10.1089/bioe.2019.0028Open DOISearch in Google Scholar

5Sersa G, Ursic K, Cemazar M, Heller R, Bosnjak M, Campana LG. Biological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap. Eur J Surg Oncol 2021; 47: 1836-46. doi: 10.1016/j.ejso.2021.03.229 Sersa G Ursic K Cemazar M Heller R Bosnjak M Campana LG Biological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap Eur J Surg Oncol 2021 47 1836 46 doi 10.1016/j.ejso.2021.03.229Open DOISearch in Google Scholar

6Gehl J, Sersa G, Matthiessen LW, Tobian M, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602 Gehl J Sersa G Matthiessen LW Tobian M Soden D Occhini A et al Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases Acta Oncol 2018 57 874 82 doi 10.1080/0284186X.2018.1454602Open DOISearch in Google Scholar

7Djokic M, Cemazar M, Bosnjak M, Dezman R, Badovinac D, Miklavcic D, et al. A prospective phase II study evaluating intraoperative electrochemotherapy of hepatocellular carcinoma. Cancers 2020; 12: E3778. doi: 10.3390/cancers12123778 Djokic M Cemazar M Bosnjak M Dezman R Badovinac D Miklavcic D et al A prospective phase II study evaluating intraoperative electrochemotherapy of hepatocellular carcinoma Cancers 2020 12 E3778 doi 10.3390/cancers12123778Open DOISearch in Google Scholar

8Edhemovic I, Brecelj E, Cemazar M, Boc N, Trotovsek B, Djokic M, et al. Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. Eur J Surg Oncol 2020; 46: 1628-33. doi: 10.1016/j. ejso.2020.04.037 Edhemovic I Brecelj E Cemazar M Boc N Trotovsek B Djokic M et al Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study Eur J Surg Oncol 2020 46 1628 33 doi 10.1016/j.ejso.2020.04.037Open DOISearch in Google Scholar

9Casadei R, Ricci C, Ingaldi C, Alberici L, Di Marco M, Guido A, et al. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience. Updat Surg 2020; 72: 1089-96. doi: 10.1007/s13304-020-00782-x Casadei R Ricci C Ingaldi C Alberici L Di Marco M Guido A et al Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience Updat Surg 2020 72 1089 96 doi 10.1007/s13304-020-00782-xOpen DOISearch in Google Scholar

10Spallek H, Bischoff P, Zhou W, de Terlizzi F, Jakob F, Kovàcs A. Percutaneous electrochemotherapy in primary and secondary liver malignancies - local tumor control and impact on overall survival. Radiol Oncol 2022; 56: 102-10. doi: 10.2478/raon-2022-0003 Spallek H Bischoff P Zhou W de Terlizzi F Jakob F Kovàcs A Percutaneous electrochemotherapy in primary and secondary liver malignancies - local tumor control and impact on overall survival Radiol Oncol 2022 56 102 10 doi 10.2478/raon-2022-0003Open DOISearch in Google Scholar

11Schipilliti FM, Onorato M, Arrivi G, Panebianco M, Lerinò D, Milano A, et al. Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach. Radiol Oncol 2022; 56: 285-91. doi: 10.2478/raon-2022-0022 Schipilliti FM Onorato M Arrivi G Panebianco M Lerinò D Milano A et al Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach Radiol Oncol 2022 56 285 91 doi 10.2478/raon-2022-0022Open DOISearch in Google Scholar

12Bosnjak M, Jesenko T, Markelc B, Cerovsek A, Sersa G, Cemazar M. Sunitinib potentiates the cytotoxic effect of electrochemotherapy in pancreatic carcinoma cells. Radiol Oncol 2022; 56: 164-72. doi: 10.2478/raon-2022-0009 Bosnjak M Jesenko T Markelc B Cerovsek A Sersa G Cemazar M Sunitinib potentiates the cytotoxic effect of electrochemotherapy in pancreatic carcinoma cells Radiol Oncol 2022 56 164 72 doi 10.2478/raon-2022-0009Open DOISearch in Google Scholar

13Perrone AM, Galuppi A, Pirovano C, Borghese G, Covarelli P, De Terlizi F, et al. Palliative electrochemotherapy in vulvar carcinoma: preliminary results of the ELECHTRA (Electrochemotherapy Vulvar Cancer) multicenter study. Cancers 2019; 11: E657. doi: 10.3390/cancers11050657 Perrone AM Galuppi A Pirovano C Borghese G Covarelli P De Terlizi F et al Palliative electrochemotherapy in vulvar carcinoma: preliminary results of the ELECHTRA (Electrochemotherapy Vulvar Cancer) multicenter study Cancers 2019 11 E657 doi 10.3390/cancers11050657Open DOISearch in Google Scholar

14Tranoulis A, Georgiou D, Founta C, Mehra G, Sayasneh A, Nath R. Use of electrochemotherapy in women with vulvar cancer to improve quality-of-life in the palliative setting: a meta-analysis. Int J Gynecol Cancer 2020; 30: 107-14. doi: 10.1136/ijgc-2019-000868 Tranoulis A Georgiou D Founta C Mehra G Sayasneh A Nath R Use of electrochemotherapy in women with vulvar cancer to improve quality-of-life in the palliative setting: a meta-analysis Int J Gynecol Cancer 2020 30 107 14 doi 10.1136/ijgc-2019-000868Open DOISearch in Google Scholar

15Merlo S, Vivod G, Bebar S, Bosnjak M, Cemazar M, Srsa G, et al. Literature review and our experience with bleomycin-based electrochemotherapy for cutaneous vulvar metastases from endometrial cancer. Technol Cancer Res Treat 2021; 20: 15330338211010134. doi: 10.1177/15330338211010134 Merlo S Vivod G Bebar S Bosnjak M Cemazar M Srsa G et al Literature review and our experience with bleomycin-based electrochemotherapy for cutaneous vulvar metastases from endometrial cancer Technol Cancer Res Treat 2021 20 15330338211010134 doi 10.1177/15330338211010134Open DOISearch in Google Scholar

16Corrado G, Cutillo G, Fragomeni SM, Bruno V, Tagliaferri L, Mancini E, et al. Palliative eletrochemotherapy in primary or recurrent vulvar cancer. Int J Gynecol Cancer 2020; 30: 927-31. doi: 10.1136/ijgc-2019-001178 Corrado G Cutillo G Fragomeni SM Bruno V Tagliaferri L Mancini E et al Palliative eletrochemotherapy in primary or recurrent vulvar cancer Int J Gynecol Cancer 2020 30 927 31 doi 10.1136/ijgc-2019-001178Open DOISearch in Google Scholar

17Perrone AM, Galuppi A, Borghese G, Corti B, Ferioli M, Della Gatta AN, et al. Electrochemotherapy pre-treatment in primary squamous vulvar cancer. Our preliminary experience. J Surg Oncol 2018; 117: 1813-7. doi: 10.1002/jso.25072 Perrone AM Galuppi A Borghese G Corti B Ferioli M Della Gatta AN et al Electrochemotherapy pre-treatment in primary squamous vulvar cancer. Our preliminary experience J Surg Oncol 2018 117 1813 7 doi 10.1002/jso.25072Open DOISearch in Google Scholar

18Pellegrino A, Damiani GR, Mangioni C, Stripoli D, Loverro G, Cappello A, et al. Outcomes of bleomycin-based electrochemotherapy in patients with repeated loco-regional recurrences of vulvar cancer. Acta Oncol 2016; 55: 619-24. doi: 10.3109/0284186X.2015.1117134 Pellegrino A Damiani GR Mangioni C Stripoli D Loverro G Cappello A et al Outcomes of bleomycin-based electrochemotherapy in patients with repeated loco-regional recurrences of vulvar cancer Acta Oncol 2016 55 619 24 doi 10.3109/0284186X.2015.1117134Open DOISearch in Google Scholar

19Vivod G, Kovacevic N, Čemažar M, et al. Electrochemotherapy as an alternative treatment option to pelvic exenteration for recurrent vulvar cancer of the perineum region. Technol Cancer Res Treat 2022; 21: 15330338221116488. doi: 10.1177/15330338221116489 Vivod G Kovacevic N Čemažar M et al Electrochemotherapy as an alternative treatment option to pelvic exenteration for recurrent vulvar cancer of the perineum region Technol Cancer Res Treat 2022 21 15330338221116488 doi 10.1177/15330338221116489Open DOISearch in Google Scholar

20Perrone AM, Galuppi A, Cima S, Pozatti F, Arcelli A, Cortesi A, et al. Electrochemotherapy can be used as palliative treatment in patients with repeated loco-regional recurrence of squamous vulvar cancer: a preliminary study. Gynecol Oncol 2013; 130: 550-3. doi: 10.1016/j.ygyno.2013.06.028 Perrone AM Galuppi A Cima S Pozatti F Arcelli A Cortesi A et al Electrochemotherapy can be used as palliative treatment in patients with repeated loco-regional recurrence of squamous vulvar cancer: a preliminary study Gynecol Oncol 2013 130 550 3 doi 10.1016/j.ygyno.2013.06.028Open DOISearch in Google Scholar

21Perrone AM, Cima S, Pozzati F, Fraculli R, Cammelli S, Tesei M, et al. Palliative electro-chemotherapy in elderly patients with vulvar cancer: a phase II trial: Electro-chemotherapy in vulvar cancer. J Surg Oncol 2015; 112: 529-32. doi: 10.1002/jso.24036 Perrone AM Cima S Pozzati F Fraculli R Cammelli S Tesei M et al Palliative electro-chemotherapy in elderly patients with vulvar cancer: a phase II trial: Electro-chemotherapy in vulvar cancer J Surg Oncol 2015 112 529 32 doi 10.1002/jso.24036Open DOISearch in Google Scholar

22Clover AJP, de Terlizzi F, Bertino G, Curatolo O, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019). Eur J Cancer 2020; 138: 30-40. doi: 10.1016/j.ejca.2020.06.020 Clover AJP de Terlizzi F Bertino G Curatolo O Odili J Campana LG et al Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019) Eur J Cancer 2020 138 30 40 doi 10.1016/j.ejca.2020.06.020Open DOISearch in Google Scholar

23Groselj A, Kranjc S, Bosnjak M, Krzan M, Kosjek T, Prevc A, et al. Vascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy. Basic Clin Pharmacol Toxicol 2018; 123: 247-56. doi: 10.1111/bcpt.13012 Groselj A Kranjc S Bosnjak M Krzan M Kosjek T Prevc A et al Vascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy Basic Clin Pharmacol Toxicol 2018 123 247 56 doi 10.1111/bcpt.13012Open DOISearch in Google Scholar

24Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sergent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026 Eisenhauer EA Therasse P Bogaerts J Schwartz LH Sergent D Ford R et al New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 2009 45 228 47 doi 10.1016/j.ejca.2008.10.026Open DOISearch in Google Scholar

25Zmuc J, Gasljevic G, Sersa G, Edhemovic I, Boc N, Seliskar A, et al. Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with bleomycin in pigs. Sci Rep 2019; 9: 1-11. doi: 10.1038/s41598-019-40395-y Zmuc J Gasljevic G Sersa G Edhemovic I Boc N Seliskar A et al Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with bleomycin in pigs Sci Rep 2019 9 1 11 doi 10.1038/s41598-019-40395-yOpen DOISearch in Google Scholar

26Wei J, Hu M, Du H. Improving cancer immunotherapy: exploring and targeting metabolism in hypoxia microenvironment. Front Immunol 2022; 13: 845923. doi: 10.3389/fimmu.2022.845923 Wei J Hu M Du H Improving cancer immunotherapy: exploring and targeting metabolism in hypoxia microenvironment Front Immunol 2022 13 845923 doi 10.3389/fimmu.2022.845923Open DOISearch in Google Scholar

27Tannock IF, Gordon Steel G. Cell proliferation, drug distribution and therapeutic effects in relation to the vascular system of solid tumours. Br J Cancer 2022 Dec 23. [Ahead of print]. doi: 10.1038/s41416-022-02109-6 Tannock IF Gordon Steel G Cell proliferation, drug distribution and therapeutic effects in relation to the vascular system of solid tumours Br J Cancer 2022 Dec 23 Ahead of print doi 10.1038/s41416-022-02109-6Open DOISearch in Google Scholar

28Calvet CY, Mir LM. The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev 2016; 35: 165-77. doi: 10.1007/s10555-016-9615-3 Calvet CY Mir LM The promising alliance of anti-cancer electrochemotherapy with immunotherapy Cancer Metastasis Rev 2016 35 165 77 doi 10.1007/s10555-016-9615-3Open DOISearch in Google Scholar

29Ursic K, Kos S, Kamensek U, Cemazar M, Miceska S, Markelc B, et al. Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. J Control Release 2021; 332: 623-35. doi: 10.1016/j.jconrel.2021.03.009 Ursic K Kos S Kamensek U Cemazar M Miceska S Markelc B et al Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status J Control Release 2021 332 623 35 doi 10.1016/j.jconrel.2021.03.009Open DOISearch in Google Scholar